OGN vs ORMP
Organon & Co (OGN) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the OGN and ORMP stock pages for the full models.
Not investment advice.